TIGECICLINA FRESENIUS KABI 50mg 10mg / ml powder infusion solution medication leaflet

J01AA12 tigecycline • Antiinfectives for systemic use | Tetracyclines

Tigecycline is an antibiotic from the glycylcycline class used for the treatment of complicated bacterial infections, including intra-abdominal infections, skin and soft tissue infections, and hospital-acquired pneumonia. It works by inhibiting bacterial protein synthesis and has a broad spectrum of activity against gram-positive, gram-negative, and anaerobic bacteria.

The medication is administered intravenously, as directed by a doctor, and the dosage is adjusted based on the severity of the infection and the patient's condition. It is primarily used for infections caused by bacteria resistant to other antibiotics.

Patients should be monitored for potential side effects, such as nausea, vomiting, diarrhea, or injection site reactions. It is important for patients to inform their doctor of any unusual symptoms.

Common side effects include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, severe reactions such as pancreatitis or superinfections may occur. Patients should be informed of these risks before starting treatment.

General data about TIGECICLINA FRESENIUS KABI 50mg 10mg / ml

Substance: tigecycline

Date of last drug list: 01-10-2021

Commercial code: W67172001

Concentration: 10mg / ml

Pharmaceutical form: powder infusion solution

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for tigecycline

10mg/ml, 50mg

Other substances similar to tigecycline